Scientists make COVID receptor protein in mouse cells

A team of scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory and Columbia University has demonstrated a way to produce large quantities of the receptor that SARS-CoV-2, the virus that causes ...

New possibilities for the medical use of botulinun toxin A1

PSI researchers have discovered a surprising trick that could expand the possibilities for medical use of botulinun toxin A1, better known under the name Botox, as an active agent. They have developed antibody-like proteins ...

When growth becomes a weakness for cancer cells

ETH researchers are shedding light on what can happen when cells exceed their normal size and become senescent. The new findings could help to optimize cancer therapies.

page 4 from 33